Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 200

    Teva to recall blood pressure medicines containing Valsartan in US

    Teva to recall blood pressure medicines containing Valsartan in US

    Medical Dialogues Bureau28 Nov 2018 4:13 PM IST
    New Delhi: Teva Pharmaceutical Industries Ltd is recalling certain combinations of blood pressure drug valsartan in the United States following the...
    Tarapur facility receives EIR from US FDA: Lupin

    Tarapur facility receives EIR from US FDA: Lupin

    Medical Dialogues Bureau28 Nov 2018 4:08 PM IST
    Mumbai: In a recent press release pharma major Lupin announced the receipt of the Establishment Inspection Report (EIR) on the completion of an...
    Loxo,Bayer gets U.S approval for cancer drug Larotrectinib

    Loxo,Bayer gets U.S approval for cancer drug Larotrectinib

    Medical Dialogues Bureau28 Nov 2018 9:06 AM IST
    New Delhi: A Loxo Oncology Inc drug larotrectinib shown to be effective against a wide variety of cancers driven by a single, rare genetic mutation...
    Sun Pharma to acquire Japan

    Sun Pharma to acquire Japan's Pola Pharma for Rs 7 crores approx

    Medical Dialogues Bureau27 Nov 2018 4:20 PM IST
    New Delhi: Sun Pharma on Monday said it will acquire Japan-based Pola Pharma for around USD 1 million, (approximately Rs 7 crores) to strengthen its...
    Alembic Pharmaceuticals gets USFDA nod for pain relief ointment -Xylocaine

    Alembic Pharmaceuticals gets USFDA nod for pain relief ointment -Xylocaine

    Medical Dialogues Bureau27 Nov 2018 1:19 PM IST
    NEW DELHI: Alembic Pharmaceuticals Monday said its joint venture Aleor Dermaceuticalshas received approval from the US health regulator for Xylocaine...
    Sun Pharmaceutical, subsidiary enter settlements in Modafinil antitrust litigation

    Sun Pharmaceutical, subsidiary enter settlements in Modafinil antitrust litigation

    Medical Dialogues Bureau27 Nov 2018 1:18 PM IST
    New Delhi: Drug major Sun Pharmaceutical Industries on Monday said the company along with its subsidiary has entered into settlements with certain...
    Lupin gets USFDA nod generic Clomipramine Hydrochloride capsules

    Lupin gets USFDA nod generic Clomipramine Hydrochloride capsules

    Medical Dialogues Bureau27 Nov 2018 1:17 PM IST
    New Delhi: Drug firm Lupin on Monday said it has received approvals from the US health regulator for its Clomipramine Hydrochloride capsules, and...
    Merck appoints Jasper Bos as Managing Director of venture capital arm M Ventures

    Merck appoints Jasper Bos as Managing Director of venture capital arm M Ventures

    Medical Dialogues Bureau26 Nov 2018 2:11 PM IST
    Germany: Merck, in their recent press release announced the appointment of Jasper Bos as the new Managing Director of its strategic corporate venture...
    Glenmark Pharma gets tentative USFDA nod for Clobetasol Propionate foam to treat Skin ailments

    Glenmark Pharma gets tentative USFDA nod for Clobetasol Propionate foam to treat Skin ailments

    Medical Dialogues Bureau26 Nov 2018 12:21 PM IST
    New Delhi: Glenmark Pharmaceuticals Monday said it has received a tentative nod from the US health regulator for Clobetasol Propionate foam, used to...
    U.S. benefits manager baulks after Novartis values gene therapy at $4-5 million

    U.S. benefits manager baulks after Novartis values gene therapy at $4-5 million

    Medical Dialogues Bureau26 Nov 2018 9:59 AM IST
    ZURICH: Just weeks after Novartis floated the idea that $4-5 million was fair value for its new gene therapy against a deadly neuromuscular disease, a...
    Pricing might be tested with costly eye therapy: Novartis

    Pricing might be tested with costly eye therapy: Novartis

    Medical Dialogues Bureau26 Nov 2018 9:38 AM IST
    ZURICH: Novartis price-setting muscle is about to be tested after it won European Union approval for a blindness-fighting gene therapy whose $850,000...
    Lupin launches ANYA- Indias first chatbot for patients

    Lupin launches ANYA- India's first chatbot for patients

    Medical Dialogues Bureau25 Nov 2018 12:57 PM IST
    Ahmedabad: Pharma major Lupin announced the launch of a chatbot named ‘ANYA’ specially designed to provide medically verified information for...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Bayer appoints Bijoy Sagar as new Chief Information Technology & Digital Transformation Officer

    Bayer appoints Bijoy Sagar as new Chief Information Technology & Digital Transformation Officer

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok